OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron

Free Radical Research

Volumn 29, Issue 5, 1998, Pages 389-398

  Li, Wei ^a,b   Yuan, Xi Ming ^a   Brunk, Ulf T ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Low molecular weight iron; Lysosomes; Macrophages; Oxidative stress; Oxidized LDL

Indexed keywords

ALDEHYDE; DEFEROXAMINE; IRON; IRON COMPLEX; LIPID PEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER;

AEROBIC METABOLISM; ANIMAL CELL; APOPTOSIS; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; CELL DAMAGE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; LYSOSOME; MACROPHAGE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; RUPTURE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CELL SURVIVAL; DEFEROXAMINE; DNA FRAGMENTATION; IRON; IRON CHELATING AGENTS; LIPOPROTEINS, LDL; LYSOSOMES; MACROPHAGES; MICE; OXIDATION-REDUCTION;

ANIMALIA;

EID: 0032418899     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715769800300431     Document Type: Article

References (39)

1. G. Hoppe, J. O'Neil and H.F. Hoff (1994) Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. Journal of Clinical Investigation, 94, 1506-1512.
2. J. O'Neil, G. Hoppe, L.M. Sayre and H.F. Hoff (1997) Inactivation of cathepsin B by oxidized LDL involves complex formation induced by binding of putative reactive sites exposed at low pH to thiols on the enzyme. Free Radical Biology and Medicine, 23, 215-225.
3. M. Lougheed, H. Zhang and U.P. Steinbrecher (1991) Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. Journal of Biological Chemistry, 266, 14519-14525.
4. W. Jessup, E.L. Mander and R.T. Dean (1992) The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochimica et Biophysica Acta, 1126, 167-177.
5. S.J. Hardwick, L. Hegyi, K. Clare, N.S. Law, K.L.H. Carpenter, M.J. Mitchinson and J.N. Skepper (1996) Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. Journal of Pathology, 179, 294-302.
6. I. Escargueil-Blanc, O. Meilhac, M.T. Pieraggi, J.F. Arnal, R. Salvayre and A. Negre-Salvayre (1997) Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 331-339.
7. J.P. Thomas, P.G. Geiger and A.W. Girotti (1993) Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. Journal of Lipid Research, 34, 479-490.
8. M.D. Coffey, R.A. Cole, S.M. Colles and G.M. Chisolm (1995) In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. Journal of Clinical Investigation, 96, 1866-1873.
9. J.R. Guyton, M.L. Lenz, B. Mathews, H. Hughes, D. Karsan, E. Selinger and C.V. Smith (1995) Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis, 118, 237-249.
10. X.M. Yuan, W. Li, A.G. Olsson and U.T. Brunk (1997) The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. Atherosclerosis, 133, 153-161.
11. W. Li, X.M. Yuan, A.G. Olsson and U.T. Brunk (1998) Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 177-184.
12. L. Monney, R. Olivier, I. Otter, B. Jansen, G.G. Poirier and C. Borner (1998) Role of an acidic compartment in tumor-necrosis-factor-alpha-mduced production of ceramide, activation of caspase-3 and apoptosis. European Journal of Biochemistry, 251, 295-303.
13. L.P. Deiss, H. Galinka, H. Barissi, O. Cohen and A. Kimichi (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO Journal, 15, 3861-3870.
14. U.T. Brunk, H. Dalen, K. Roberg and H.B. Hellquist (1997) Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radical Biology and Medicine, 23, 616-626.
15. V.L. Sheen and J.D. Macklis (1994) Apoptotic mechanisms in targeted neuronal cell death by chromophore-activated photolysis. Experimental Neurology, 130, 67-81.
16. H.B. Hellquist, I. Svensson and U.T. Brunk (1997) Oxidant-induced apoptosis: a consequence of lethal lysosomal leak? Redox Report, 3, 65-70.
17. K. Roberg and K. Öllinger (1998) Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. American Journal of Pathology, 152, 1151-1156.
18. U.T. Brunk and I. Svensson (1998) Oxidative stress, growth-factor starvation, and Fas-activation may all cause apoptosis through lysosomal leak. Redox Report, (in press).
19. B. Halliwell and J.M.C. Gutteridge (1989) Lipid peroxidation: a radical chain reaction. In Free Radicals in Biology and Medicine, Clarendon Press, Oxford, pp. 188-218.
20. U.T. Brunk, C.B. Jones and R.S. Sohal (1992) A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutation Research, 275, 395-403.
21. U.T. Brunk, H. Zhang, K. Roberg and K. Öllinger (1995) Lethal hydrogen peroxide toxicity involves lysosomal iron-catalyzed reactions with membrane damage. Redox Report, 1, 267-277.
22. X.M. Yuan, W. Li, A.G. Olsson and U.T. Brunk (1997) Ferritin accumulation in human atheromas and its relation to apoptosis. XIth International Symposium on Atherosclerosis 1997, Paris. Atherosclerosis, 134-258.
23. R.J. Havel, H.A. Eder and J.H. Bragdon (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation, 34, 1345-1353.
24. M.J. Rogers, K.M. Chilton, F.P. Coxon, J. Lawry, M.O. Smith, S. Suri, R.G. Russell (1996) Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. Journal of Bone & Mineral Research, 11, 1482-1491.
25. S. Dimmeler, J. Haendeler, J. Galle and A.M. Zeiher (1997) Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation, 95, 1760-1763.
26. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells. Journal of Lipid Research, 38, 2049-2061.
27. J.B. Lloyd, H. Cable and C. Rice-Evans (1991) Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochemical Pharmacology, 41, 1361-1363.
28. B.T. Olejnicka, K. Öllinger and U.T. Brunk (1997) A short exposure to a high-glucose milieu stabilizes the acidic vacuolar apparatus of insulinoma cells in culture to ensuing oxidative stress. APMIS, 105, 689-698.
29. I. Morel, J. Cillard, G. Lescoat, O. Sergent, N. Pasdeloup, A.Z. Ocaktan, M.A. Abdallah, P. Brissot and P. Cillard (1992) Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Free Radical Biology and Medicine, 13, 499-508.
30. E. Porreca, S. Ucchino, C. Di Febbo, N. Di Bartolomeo, D. Angelucci, A.M. Napolitano, A. Mezzetti and F. Cuccurullo (1994) Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arteriosclerosis and Thrombosis, 14, 299-304.
31. D. Hileti, P. Panayiotidis and A.V. Hoffbrand (1995) Iron chelators induce apoptosis in proliferating cells. British Journal of Haematology, 89, 181-187.
32. C. deDuve and R. Wattiaux (1966) Functions of lysosomes. Annual Review of Physiology, 28, 435-492.
33. C. deDuve (1969) The lysosome in retrospect. In: Dingle, J.T. Fell, H.B. Lysosomes in Biology and Pathology. Vol 1. North Holland: Amsterdam, 3.
34. U.T. Brunk and J.L. Ericsson (1972) The demonstration of acid phosphatase in vitro cultured tissue cells. Studies on the significance of fixation, tonicity and permeability. Histochemical Journal, 4, 349-363.
35. U.T. Brunk, H. Zhang, H. Dalen and K. Öllinger (1995) Exposure of cells to non-lethal concentrations of hydrogen peroxide induces degeneration-repair mechanisms involving lysosomal destabilization. Free Radical Biology and Medicine, 19, 813-822.
36. J.M. Dypbukt, M. Ankarcrona, M. Burkitt, A. Sjöholm, K. Ström, S. Orrenius and P. Nicotera (1994) Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. Journal of Biological Chemistry, 269, 30553-30560.
37. E. Nilsson, R. Ghassernifar and U.T. Brunk (1997) Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochemical Journal, 29, 857-865.
38. R. Kinscherf, R. Claus, H.P. Deigner, O. Nauen, C. Gehrke, A. Hermetter, S. Russwurm, V. Daniel, V. Hack and J. Metz (1997) Modified low density lipoprotein delivers substrate for ceramide formation and stimulates the sphingomyelin-ceramide pathway in human macrophages. FEBS Letters, 405, 55-59.
39. S.L. Schissel, J. Tweedie-Hardman, J.H. Rapp, G. Graham, K.J. Williams and I. Tabas (1996) Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. Journal of Clinical Investigation, 98, 1455-1464.